menu
    • menu

    Company profile for CytoMed Therapeutics

    NEW Drugs in Dev: 3
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Incorporated in 2018, CytoMed is a biotech company spun off from the Agency for Science, Technology and Research (A*STAR), Singapore’s leading research and development agency in the public sector, and focused on translating its proprietary technologies into cell-based immunotherapy cancer treatments. The development of these novel technologies was inspired by the clinical success of chimeric antigen receptor-modified T (CAR-...
    Incorporated in 2018, CytoMed is a biotech company spun off from the Agency for Science, Technology and Research (A*STAR), Singapore’s leading research and development agency in the public sector, and focused on translating its proprietary technologies into cell-based immunotherapy cancer treatments. The development of these novel technologies was inspired by the clinical success of chimeric antigen receptor-modified T (CAR-T) cells in treating hematological malignancies and introduces solutions for the clinical limitations and commercial challenges inherent in extrapolating the CAR-T principle into treatments for solid tumors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CytoMed TherapeuticsSingapore Flag
    Country
    Country
    Singapore
    Address
    Address
    1 Commonwealth Lane #08-22, 149544
    Telephone
    Telephone
    +607-3824911
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://w2.cytomed.sg/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cytomed Therapeutics Seeks Shareholder Input On Value for Captial
    Cytomed Therapeutics Seeks Shareholder Input On Value for Captial

    13 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/13/3217726/0/en/CytoMed-Therapeutics-new-year-update-and-seeks-shareholders-feedback-on-proposal-to-improve-shareholder-value-for-their-patient-capital.html

    GLOBENEWSWIRE
    13 Jan 2026
    Share Share
    CytoMed Enters into Collaboration with Hospital Partners
    CytoMed Enters into Collaboration with Hospital Partners

    08 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/08/3201473/0/en/CytoMed-Therapeutics-Announces-Novel-First-In-Human-Clinical-Trial-Collaborations-with-Renowned-and-Prestigious-Hospital-Partner-to-Advance-Its-Off-The-Shelf-Donor-Derived-Gamma-De.html

    GLOBENEWSWIRE
    08 Dec 2025
    Share Share
    Cytomed Pharma Acquires UK T Cell Tech For Cancer Treatment
    Cytomed Pharma Acquires UK T Cell Tech For Cancer Treatment

    18 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/18/3189932/0/en/CytoMed-Therapeutics-Completes-Acquisition-of-T-Cell-Technology-from-UK-to-Treat-Cancers-in-China-and-India.html

    GLOBENEWSWIRE
    18 Nov 2025
    Share Share
    Chairman Of Cytomed Therapeutics Boosts Ownership Stake To 21.95%
    Chairman Of Cytomed Therapeutics Boosts Ownership Stake To 21.95%

    22 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/22/3171038/0/en/CytoMed-Therapeutics-Chairman-Increases-Effective-Holdings-to-21-95.html

    GLOBENEWSWIRE
    22 Oct 2025
    Share Share
    Cytomed Bids Cash For TC Biopharma Assets Acquisition
    Cytomed Bids Cash For TC Biopharma Assets Acquisition

    14 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3166116/0/en/CytoMed-makes-cash-bid-for-potential-acquisition-of-TC-BioPharm-Limited-s-relevant-assets.html

    GLOBENEWSWIRE
    14 Oct 2025
    Share Share
    CytoMed Therapeutics & MD Anderson Publish ?? T Cell AML Study
    CytoMed Therapeutics & MD Anderson Publish ?? T Cell AML Study

    02 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/02/3160232/0/en/CytoMed-Therapeutics-Announces-Publication-of-Collaborative-Research-with-The-University-of-Texas-MD-Anderson-Cancer-Center-Demonstrating-the-Potential-of-Allogeneic-%CE%B3%CE%B4-T-Cells-in-.html

    GLOBENEWSWIRE
    02 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search